首页> 外国专利> METHOD FOR SCREENING COMPOUND INHIBITING ONSET OR PROGRESS OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND METHOD FOR DIAGNOSING FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS

METHOD FOR SCREENING COMPOUND INHIBITING ONSET OR PROGRESS OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND METHOD FOR DIAGNOSING FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS

机译:筛查家族性肌萎缩侧索硬化症的化合物抑制起病或进展的方法,以及诊断家族性肌萎缩侧索硬化症的方法

摘要

PPROBLEM TO BE SOLVED: To find out a pathway for controlling the expression of NEDL1 and to provide a method for screening a compound inhibiting the onset or progress of FALS (familial amyotrophic lateral sclerosis) by utilizing the same. PSOLUTION: This method for screening includes the following processes: a process of culturing cells under conditions of the presence and absence of a tested compound; a process of measuring the amount of expression of HIF-1α (hypoxia inducible factor-1α) in each of the cultured cells; and a process of judging that the tested compound is the compound inhibiting the onset or progress of the familial amyotrophic lateral sclerosis when the amount of expression of the HIF-1α in the cells cultured in the presence of the tested compound is smaller than that in the cells cultured in the absence of the tested compound. PCOPYRIGHT: (C)2007,JPO&INPIT
机译:<要解决的问题:寻找控制NEDL1表达的途径,并提供一种利用该化合物筛选抑制FALS(家族性肌萎缩性侧索硬化)发作或进展的化合物的方法。

解决方案:该筛选方法包括以下过程:在有和没有被测化合物的条件下培养细胞的过程;测量HIF-1α表达量的过程; (低氧诱导因子-1α)在每个培养的细胞中;以及判断HIF-1α的表达量是否为抑制家族性肌萎缩性侧索硬化的发生或发展的化合物的判断方法。在存在被测化合物的情况下培养的细胞中的细胞比在不存在被测化合物的情况下培养的细胞中的细胞小。

版权:(C)2007,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号